Are peptides legal in Kansas?

Can a Kansas resident get peptides by telehealth?

The Kansas Telemedicine Act (2018) defines telemedicine as care delivered by real-time two-way interactive audio, visual, or audio-visual communication, including secure video conferencing or store-and-forward technology used to provide or support care (K.S.A. 40-2,211). K.S.A. 40-2,212 states that telemedicine may be used to establish a valid provider-patient relationship, that in-person standards of practice and conduct apply, that the provider must give guidance on follow-up care, and that with patient consent the provider must send a report to the patient's primary care or treating physician within three business days. K.S.A. 40-2,214 directed the State Board of Healing Arts to adopt rules on prescribing by telemedicine, which the Board did in K.A.R. 100-77. Because the statutory definition centers on real-time interaction and treats store-and-forward as supporting care, it is unclear whether a purely asynchronous first encounter satisfies Kansas law. K.A.R. 100-77 has three short regulations: 100-77-1 adopts the statutory definitions, 100-77-2 deems telemedicine rendered where the patient is, and 100-77-3 says the same laws that apply to in-person prescribing, including for controlled substances, apply to prescribing by telemedicine. None of them addresses asynchronous-only prescribing, so async_prescribing_allowed is left unknown. [2] [3] [7] [8] [9]

How does the Kansas pharmacy board treat compounding?

The Kansas State Board of Pharmacy regulates pharmacies under the Kansas Pharmacy Act (K.S.A. 65-1625 and following) and Board regulations in K.A.R. Article 68. Kansas has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). K.S.A. 65-1657 bars any nonresident pharmacy from shipping, mailing, or delivering prescription drugs or devices to a patient, a patient's agent, or a prescriber's office in Kansas unless it holds an annual Kansas nonresident pharmacy registration, and it prohibits unregistered pharmacies from advertising to Kansas residents. Covering shipments to prescribers' offices matters for clinics that order compounded peptides for in-office administration. Compounding standards are in K.A.R. Article 13 of the Board's regulations: 68-13-2 (definitions), 68-13-3 (nonsterile preparations), and 68-13-4 (sterile preparations), and 68-13-4 bars compounding a sterile preparation that is essentially a copy of a commercially available drug unless the prescriber documents a clinically significant difference for the individual patient or the drug is on the federal shortage list. House Bill 2068 (2026) adopts USP chapters 795, 797, and 825 under the Kansas Pharmacy Act effective July 1, 2027, and the Board is drafting matching amendments to Article 13. [1] [4] [5] [6] [10] [11]

Can you get compounded GLP-1s in Kansas?

Kansas patients using telehealth GLP-1 programs should confirm the prescriber holds a Kansas license and that the dispensing pharmacy has a Kansas nonresident pharmacy registration under K.S.A. 65-1657. The Kansas Board of Pharmacy's statement on compounding and dispensing GLP-1 and GIP receptor agonists (last updated August 26, 2026) says semaglutide and tirzepatide are no longer in shortage, that no salt form of either may be used in a compounded drug, and that even when compounding is otherwise allowed, a non-pharmaceutical grade bulk substance or one not made in an FDA-registered establishment is prohibited. It also says pre-printed or check-box prescriptions may not document the patient-specific need that copies of approved drugs require, and that retatrutide and cagrilintide cannot be used to compound under federal law. [6] [10] [14] [15]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Kansas?

Find a provider in Kansas

• Compounding pharmacies in Kansas
• Clinics in Kansas
• Telehealth providers in Kansas

Is it legal to buy research peptides in Kansas?

K.S.A. 65-1657 bars unregistered nonresident pharmacies from shipping prescription drugs into Kansas and from advertising to Kansas residents. The Kansas Board of Pharmacy's GLP-1 statement adds that compounding pharmacies must use pharmaceutical-grade active ingredients, not research use, investigational, food, or supplement grade, with a certificate of analysis naming the original manufacturer, and that a pharmacist may not dispense a product compounded in a non-compliant manner. [6] [10] [16]

Peptide-specific notes for Kansas

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.